FDA's Office Of Prescription Drug Promotion Reviews Amgen's Submitted Video For VECTIBIX Injection For Intravenous Use; FDA Determines Video Is False Or Misleading And Breaches Federal Food, Drug, And Cosmetic Act
https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/amgen-inc-739641-08122026
Share
Why It Matters
The FDA said Amgen's video about VECTIBIX was misleading and broke the law. When a company gets told its medicine advertising is false, watch for what comes next.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.